* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected
to show a
rise in quarterly revenue when it reports results on February 1
(estimated).
* The Lakewood Colorado-based company is expected to report
a
30.1% increase in revenue to $44.467 million from $34.17 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Mesa Laboratories
Inc is
for earnings of 42 cents per share. For the same quarter last
year, the company reported a loss of 89 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $320, about 15% above its last closing price
of $271.99.
*
This summary was machine generated January 28 at 14:59 GMT. All
figures in US dollars unless otherwise stated